Correction to: Moving on obesity treatment in CKD: inertia is unjustified
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiet and metabolism studies · Diabetes Treatment and Management
This is a correction to: Carmine Zoccali, Moving on obesity treatment in CKD: inertia is unjustified, Clinical Kidney Journal, Volume 17, Issue 1, January 2024, sfad275, https://doi.org/10.1093/ckj/sfad275
In the originally published version of this article, a typographical error was present in the in-text citations of ‘Joshi S, Shi R, Patel J. Risk of ketogenic diet in CKD. Clin Kidney J 2023;17:1–5. https://doi.org/10.1093/ckj/sfad274’.
This has been corrected.